A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
Clinical trial NCT02795767 · COMPLETED
Trial details
- NCT number
- NCT02795767
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-22
- Primary completion
- 2018-04-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.